Top Markets
#1 0G 0G +24.46%
#2 SAFEcoin SAFEcoin +21.99%
#3 Zora Zora +20.33%
#4 Axelar Axelar +19.88%
#5 Full Moon Full Moon +18.98%
#6 AI XOVIA AI XOVIA +17.52%
#7 Merlin's Seal BTC Merlin's Seal BTC +16.60%
#8 Cysic Cysic +16.30%
#9 VVS Finance VVS Finance +15.88%
#10 Apertum Apertum +13.84%
Coin of the day
0G 0G
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Graphite Bio, Inc. Graphite Bio, Inc.

Graphite Bio, Inc.

GRPH
Classement en actions #12750
Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to... Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the glucocerebrosidase enzyme. Initially established as Integral Medicines, Inc., the company rebranded to Graphite Bio, Inc. in August 2020. Founded in 2017, Graphite Bio's operations are based out of its headquarters in South San Francisco, California.
Prix de l'action
$22.26
Dernière synchronisation: 2024-03-22
Capitalisation boursière
$553.40M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Graphite Bio, Inc. (GRPH)

Catégorie

Healthcare
Historique du prix de l'action pour Graphite Bio, Inc. (GRPH)
Prix de clôture le plus élevé : $23.07 le 2024-03-01

Prix de clôture le plus bas : $174.18 le 2021-06-01
Historique du prix de l'action de Graphite Bio, Inc. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2024 40.75%
2023 -26.18%
2022 -70.69%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $752.76 6.28%
CH